PFKM and breast carcinoma: There are many indications of increased expression of PFK-1, as well as its regulatory protein PFK-2, in different types of cancers, such as lung cancer (Shen et al., 2020), breast cancer (Onodera et al., 2014), hepatocellular carcinoma (Feng et al., 2020).